The recommendations come at a time when treatments for chronic lymphocytic leukemia (CLL), such as venetoclax, are making deep remissions and undetectable minimal residual disease (MRD) after a fixed ...
Test detects genetic abnormalities to aid in the prediction of chronic lymphocytic leukemia patient survival. Abbott received 510k clearance for an in vitro diagnostic test to aid in determining the ...
Diagnosis typically involves a physical exam to check for swollen lymph nodes and blood tests to measure lymphocyte counts. In some cases, bone marrow tests are used to evaluate cancer progression. CT ...